Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. (Q30209037)

10 June 2017

title

Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. (English)

1 reference

10 June 2017

main subject

United States of America

0 references

1 reference

1 reference

1 reference

21

Scott D Holmberg

1 reference

10 June 2017

14

Kristin Sweet

1 reference

10 June 2017

Anil G Suryaprasad

1

1 reference

10 June 2017

Jianglan Z White

2

1 reference

10 June 2017

Fujie Xu

3

1 reference

10 June 2017

Beth-Ann Eichler

4

1 reference

10 June 2017

Janet Hamilton

5

1 reference

10 June 2017

Ami Patel

6

1 reference

10 June 2017

Shadia Bel Hamdounia

7

1 reference

10 June 2017

Daniel R Church

8

1 reference

10 June 2017

Kerri Barton

9

1 reference

10 June 2017

Chardé Fisher

10

1 reference

10 June 2017

Kathryn Macomber

11

1 reference

10 June 2017

Marisa Stanley

12

1 reference

10 June 2017

Sheila M Guilfoyle

13

1 reference

10 June 2017

Stephen Liu

15

1 reference

10 June 2017

Kashif Iqbal

16

1 reference

10 June 2017

Rania Tohme

17

1 reference

10 June 2017

Umid Sharapov

18

1 reference

10 June 2017

Benjamin A Kupronis

19

1 reference

10 June 2017

John W Ward

20

1 reference

10 June 2017

language of work or name

English

0 references

publication date

11 August 2014

1 reference

Clinical Infectious Diseases

10 June 2017

published in

1 reference

10 June 2017

volume

59

1 reference

10 June 2017

issue

10

1 reference

10 June 2017

page(s)

1411-1419

1 reference

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

10 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Hepatitis C virus seroconversion among young injection drug users: relationships and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Population-based surveillance for hepatitis C virus, United States, 2006-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Current and future therapies for hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Geographic variation in opioid prescribing in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Estimating acute viral hepatitis infections from nationally reported cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Treatment as prevention and cure towards global eradication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Breaking the silence on viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

Confronting the emerging epidemic of HCV infection among young injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU643

21 January 2018

Identifiers

DOI

10.1093/CID/CIU643

1 reference

10 June 2017

1 reference